Literature DB >> 23271211

Conventional IVF versus ICSI in sibling oocytes from couples with endometriosis and normozoospermic semen.

Alisa Komsky-Elbaz1, Arieh Raziel, Shevach Friedler, Deborah Strassburger, Esti Kasterstein, Daphna Komarovsky, Raphael Ron-El, Ido Ben-Ami.   

Abstract

PURPOSE: This study compares the fertilization rate and embryonic development of oocytes randomly inseminated by conventional IVF or ICSI in patients with endometriosis and normozoospermic semen during IVF cycles.
METHODS: Sibling oocytes were randomized to be inseminated either by ICSI or IVF. Rates of fertilization, cleavage, blastulation and embryonic morphology were assessed.
RESULTS: A total of 786 sibling cumulus-oocyte complexes (COC) were randomized between insemination by conventional IVF (387 COC) or ICSI (399 COC). A significantly higher fertilization rate was found in the ICSI group (ICSI versus IVF, 73.3±23 % versus 54.7±31.9 % respectively; P=0.003), yielding a higher mean number of day 2 embryos (5.2±3.4 versus 3.6±2.9 respectively; P=0.002). Triploid fertilization rate (3PN/COC) was significantly higher in the IVF group compared to the ICSI group (3.9±8.7 % versus 0.9±3.1 % respectively; P=0.02). The morphology score and rate of development of day 2 and 3 embryos were not different between the two groups. Comparison of embryo transfer cycles in which either IVF or ICSI only embryos were transferred did not reveal any statistically significant differences in pregnancy or implantation rates.
CONCLUSION: ICSI appears to be a better treatment option than conventional IVF in endometriosis-associated infertility, since it offers the advantages of higher fertilization rate and mean number of embryos and lower rate of total fertilization failure and triploid fertilization.

Entities:  

Mesh:

Year:  2012        PMID: 23271211      PMCID: PMC3585678          DOI: 10.1007/s10815-012-9922-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  37 in total

1.  Conventional in-vitro fertilization versus intracytoplasmic sperm injection in sibling oocytes from couples with tubal infertility and normozoospermic semen.

Authors:  C Staessen; M Camus; K Clasen; A De Vos; A Van Steirteghem
Journal:  Hum Reprod       Date:  1999-10       Impact factor: 6.918

2.  Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure.

Authors:  Lisbet Van Landuyt; Anick De Vos; Hubert Joris; Greta Verheyen; Paul Devroey; André Van Steirteghem
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

3.  Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle.

Authors:  Sunny H Jun; Thomas O'Leary; Katharine V Jackson; Catherine Racowsky
Journal:  Fertil Steril       Date:  2006-09-11       Impact factor: 7.329

4.  Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer.

Authors:  L Pal; J L Shifren; K B Isaacson; Y Chang; L Leykin; T L Toth
Journal:  J Assist Reprod Genet       Date:  1998-01       Impact factor: 3.412

Review 5.  Endometriosis and subfertility treatment: a review.

Authors:  A De Hondt; K Peeraer; C Meuleman; L Meeuwis; P De Loecker; T M D'Hooghe
Journal:  Minerva Ginecol       Date:  2005-06

6.  Ovarian dysfunction in endometriosis-associated and unexplained infertility.

Authors:  D J Cahill; P G Wardle; L A Maile; C R Harlow; M G Hull
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

7.  IVF versus ICSI in sibling oocytes from patients with polycystic ovarian syndrome: a randomized controlled trial.

Authors:  Jiann-Loung Hwang; Kok-Min Seow; Yu-Hung Lin; Bih-Chwen Hsieh; Lee-Wen Huang; Heng-Ju Chen; Shih-Chia Huang; Chin-Yu Chen; Pei-Hsin Chen; Chii-Ruey Tzeng
Journal:  Hum Reprod       Date:  2005-02-10       Impact factor: 6.918

Review 8.  Pathogenic mechanisms in endometriosis-associated infertility.

Authors:  Sajal Gupta; Jeffrey M Goldberg; Nabil Aziz; Eric Goldberg; Natalie Krajcir; Ashok Agarwal
Journal:  Fertil Steril       Date:  2008-08       Impact factor: 7.329

9.  The contribution of subtle oocyte or sperm dysfunction affecting fertilization in endometriosis-associated or unexplained infertility: a controlled comparison with tubal infertility and use of donor spermatozoa.

Authors:  M G Hull; J A Williams; B Ray; E A McLaughlin; V A Akande; W C Ford
Journal:  Hum Reprod       Date:  1998-07       Impact factor: 6.918

10.  Attenuated oocyte fertilization and embryo development associated with altered growth factor/signal transduction induced by endometriotic peritoneal fluid.

Authors:  Guo-Lian Ding; Xi-Jing Chen; Qiong Luo; Min-Yue Dong; Ning Wang; He-Feng Huang
Journal:  Fertil Steril       Date:  2010-01-04       Impact factor: 7.329

View more
  10 in total

1.  Is intracytoplasmic sperm (ICSI) better than traditional in vitro fertilization (IVF): confirmation of higher blastocyst rates per oocyte using a split insemination design.

Authors:  May-Tal Sauerbrun-Cutler; Warren J Huber; Phinnara Has; Chloe Shen; Richard Hackett; Ruben Alvero; Shunping Wang
Journal:  J Assist Reprod Genet       Date:  2020-05-20       Impact factor: 3.412

2.  CONTROLLED OVARIAN STIMULATION IN ENDOMETRIOSIS PATIENTS CAN BE INDIVIDUALIZED BY ANTI-MÜLLERIAN HORMONE LEVELS.

Authors:  E Hosseini; F Nikmard; B Aflatoonian; S Vesali; T Alenabi; A Aflatoonian; F Mehraein; R Aflatoonian
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Apr-Jun       Impact factor: 0.877

3.  ICSI treatment of severe male infertility can achieve prospective embryo quality compared with IVF of fertile donor sperm on sibling oocytes.

Authors:  Ju-Fen Zheng; Xiao-Bao Chen; Lei-Wen Zhao; Min-Zhi Gao; Jie Peng; Xian-Qin Qu; Hui-Juan Shi; Xing-Liang Jin
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

Review 4.  Is the oocyte quality affected by endometriosis? A review of the literature.

Authors:  Ana Maria Sanchez; Valeria Stella Vanni; Ludovica Bartiromo; Enrico Papaleo; Eran Zilberberg; Massimo Candiani; Raoul Orvieto; Paola Viganò
Journal:  J Ovarian Res       Date:  2017-07-12       Impact factor: 4.234

5.  Differences in utilization of Intracytoplasmic sperm injection (ICSI) within human services (HHS) regions and metropolitan megaregions in the U.S.

Authors:  Pavel Zagadailov; Albert Hsu; David B Seifer; Judy E Stern
Journal:  Reprod Biol Endocrinol       Date:  2017-06-12       Impact factor: 5.211

Review 6.  The effectiveness of ICSI versus conventional IVF in couples with non-male factor infertility: study protocol for a randomised controlled trial.

Authors:  V Q Dang; L N Vuong; T M Ho; A N Ha; Q N Nguyen; B T Truong; Q T Pham; R Wang; R J Norman; B W Mol
Journal:  Hum Reprod Open       Date:  2019-03-27

7.  Prognosis in fertilisation rate and outcome in IVF cycles in patients with and without endometriosis: a population-based comparative cohort study with controls.

Authors:  J Metzemaekers; Eer Lust; Jpt Rhemrev; N Van Geloven; Arh Twijnstra; L Van Der Westerlaken; F W Jansen
Journal:  Facts Views Vis Obgyn       Date:  2021-03-31

8.  Effectivity of conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) when male factor is absent: a perspective point of view.

Authors:  Marcelo Giacobbe; Maiara Conatti; Alecsandra Gomes; Tatiana Cs Bonetti; Pedro Aa Monteleone
Journal:  JBRA Assist Reprod       Date:  2022-01-17

Review 9.  Opportunities and Limits of Conventional IVF versus ICSI: It Is Time to Come off the Fence.

Authors:  Martina Balli; Anna Cecchele; Valerio Pisaturo; Sofia Makieva; Giorgia Carullo; Edgardo Somigliana; Alessio Paffoni; Paola Vigano'
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

Review 10.  Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility.

Authors:  Amir Shahreza Patel; Joon Yau Leong; Libert Ramos; Ranjith Ramasamy
Journal:  World J Mens Health       Date:  2018-10-10       Impact factor: 5.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.